AGREEMENT TO TRANSFER OF OPERATING AGREEMENTTransfer of Operating Agreement • March 11th, 2008 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations
THIS AGREEMENT TO TRANSFER OF OPERATING AGREEMENT (this “Agreement”) is entered into as of March 10, 2008, by and among Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd., a Cayman Islands company incorporated under the laws of the Cayman Islands (“Skystar Cayman”), Sida Biotechnology (Xian) Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China and a wholly foreign owned enterprise (“Sida”), Weibing Lu, chairman and shareholder of Xian Tianxing Bio-Pharmaceutical Co., Ltd., a company with joint stock limited liability organized under the laws of the PRC (“Tianxing”), certain shareholders of Tianxing (collectively with Weibing Lu, the “Shareholders”) who are signatories to that certain Operating Agreement dated as of October 28, 2005 (the “Operating Agreement”), and Skystar Bio-Pharmaceutical Company, a Nevada corporation (“Skystar”). Skystar Cayman, Sida and the Shareholders are collectively referred to as the “Parties”. Skystar is made a
AMENDMENT TO EQUITY PLEDGE AGREEMENTEquity Pledge Agreement • March 11th, 2008 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations
THIS AMENDMENT TO EQUITY PLEDGE AGREEMENT (this “Amendment”) is entered into as of March 10, 2008, by and among Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd., a Cayman Islands company incorporated under the laws of the Cayman Islands (“Skystar Cayman”), Sida Biotechnology (Xian) Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China (“PRC”) and a wholly foreign owned enterprise (“Sida”), Xian Tianxing Bio-Pharmaceutical Co., Ltd., a company with joint stock limited liability organized under the laws of the PRC (“Tianxing”), and those shareholders of Tianxing as set forth on the signature page (collectively “Pledgors”, and with Skystar Cayman, Sida and Tianxing collectively referred to as the “Parties”).
DESIGNATION AGREEMENTDesignation Agreement • March 11th, 2008 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations
THIS DESIGNATION AGREEMENT (this “Agreement”) is entered into as of March 10, 2008, by and among Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd., a Cayman Islands company incorporated under the laws of the Cayman Islands (“Skystar Cayman”), Sida Biotechnology (Xian) Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China and a wholly foreign owned enterprise (“Sida”), Xian Tianxing Bio-Pharmaceutical Co., Ltd., a company with joint stock limited liability organized under the laws of the PRC (“Tianxing”), Weibing Lu, chairman and shareholder of Tianxing (“Chairman”), certain shareholders of Tianxing (the “Shareholders”) who are signatories to that certain Proxy Agreement dated as of October 28, 2005 (the “Proxy Agreement”), and Skystar Bio-Pharmaceutical Company, a Nevada corporation (“Skystar”). Skystar Cayman and Sida are collectively referred to as the “Parties”. Tianxing, Chairman, the Shareholders and Skystar are each made a party to
AMENDMENT TO CONSULTING SERVICES AGREEMENTConsulting Services Agreement • March 11th, 2008 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations
THIS AMENDMENT TO CONSULTING SERVICES AGREEMENT (this “Amendment”) is entered into as of March 10, 2008, by and among Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd., a Cayman Islands company incorporated under the laws of the Cayman Islands (“Skystar Cayman”), Sida Biotechnology (Xian) Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China (“PRC”) and a wholly foreign owned enterprise (“Sida”), Xian Tianxing Bio-Pharmaceutical Co., Ltd., a company with joint stock limited liability organized under the laws of the PRC (“Tianxing”), and Skystar Bio-Pharmaceutical Company, a Nevada corporation (“Skystar”). Skystar Cayman, Sida and Tianxing are collectively referred to as the “Parties”. Skystar is made a party to this Agreement for the sole purpose of acknowledging the Agreement.
AGREEMENT TO TRANSFER OF OPTION AGREEMENTOption Agreement • March 11th, 2008 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations
THIS AGREEMENT TO TRANSFER OF OPTION AGREEMENT (this “Agreement”) is entered into as of March 10, 2008, by and among Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd., a Cayman Islands company incorporated under the laws of the Cayman Islands (“Skystar Cayman”), Sida Biotechnology (Xian) Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China and a wholly foreign owned enterprise (“Sida”) and Skystar Bio-Pharmaceutical Company, a Nevada corporation (“Skystar”, and with Skystar Cayman and Sida, collectively referred to as the “Parties”). Skystar is made a party to this Agreement for the sole purpose of acknowledging the Agreement.
